We have updated our Terms of Use.
Please read our new Privacy Statement before continuing.

Not elementary

18 February 2016 By Robert Cyran

Big Blue’s market value rose by about $6 bln after it agreed to buy a healthcare analytics firm for $2.6 bln. Giving IBM’s artificial-intelligence platform more data to chew on is useful, but investors’ glee over an opaque addition to an enigmatic business effort is confusing.

This content is for Subscribers only

or
If you need assistance please email breakingviews.clientsupport@thomsonreuters.com
 

Email a friend

Please complete the form below.

Required fields *

*
*
*

(Separate multiple email addresses with commas)

We need you to verify your email address to continue. Please check your email/junk folder for our verification request.

Click here to resend the verification email.